News | Stents Drug Eluting | July 02, 2024

Biotronik Introduces Expanded Maximum Diameter Dimensions for Orsiro Mission DES

Globally approved maximum diameter expansion aims to provide new options in larger diameter and tapered vessels  

Globally approved maximum diameter expansion aims to provide new options in larger diameter and tapered vessels

July 2, 2024 —  Biotronik announced the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro Mission Drug Eluting Stent (DES). Diameters 2.25 mm to 3.00 mm of the Orsiro Mission DES can now be extended up to 4.0mm, while diameters 3.5 mm and 4.0 mm can reach up to 5.0 mm. 

This new MAD expansion follows the approvals from CE, FDA, and Health Canada obtained in the past months. This update reflects a global effort for the Orsiro Mission stent technology to match contemporary Percutaneous Coronary Intervention (PCI), enabling practitioners to optimize vessel apposition and conform to tapered anatomies. 

Subsequently to these approvals, an updated labeling, additionally to the modified Instructions for Use (IFU), will provide further guidance to practitioners. 

Always consult the Instructions for Use specific to your country when applying the Maximum Allowed Diameters (MAD). 

For more information: www.biotronik.com


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now